ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+3.47%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$718M
AUM Growth
+$718M
(+3%)
Cap. Flow
+$7.23M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
54.68%
Holding
33
New
7
Increased
8
Reduced
9
Closed
8
Top Buys
| 1 |
DaVita
DVA
|
$51.2M |
| 2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$31.7M |
| 3 |
UnitedHealth
UNH
|
$30.1M |
| 4 |
Surgery Partners
SGRY
|
$29M |
| 5 |
ICU Medical
ICUI
|
$27.2M |
Top Sells
| 1 |
Humana
HUM
|
$61.3M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$36.3M |
| 3 |
Hologic
HOLX
|
$24.5M |
| 4 |
HCA Healthcare
HCA
|
$23.6M |
| 5 |
Boston Scientific
BSX
|
$21.7M |
Sector Composition
| 1 | Healthcare | 98.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DaVita
DVA
$9.85B
| $51.2M | 7.13% | +450,000 | New | +$51.2M |
|
2
Envista
NVST
$3.52B
| $47.8M | 6.66% | 1,060,000 -408,787 | -28% | -$18.4M |
|
3
Guardant Health
GH
$8.41B
| $44M | 6.14% | 440,255 +250,255 | +132% | +$25M |
|
|
CTLT
4
DELISTED
CATALENT, INC.
CTLT
| $40.5M | 5.65% | 316,661 +56,661 | +22% | +$7.25M |
|
5
Acadia Healthcare
ACHC
$2.12B
| $38.4M | 5.35% | 632,189 +311,189 | +97% | +$18.9M |
|
6
United Therapeutics
UTHR
$13.8B
| $36.7M | 5.12% | 170,000 +100,000 | +143% | +$21.6M |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $34.2M | 4.77% | 422,260 +18,836 | +5% | +$1.53M |
|
8
Icon
ICLR
$13.8B
| $34.1M | 4.75% | 110,000 -20,000 | -15% | -$6.19M |
|
9
AbbVie
ABBV
$372B
| $33.9M | 4.72% | 250,000 -143,024 | -36% | -$19.4M |
|
|
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
| $31.7M | 4.41% | +750,000 | New | +$31.7M |
|
11
Molina Healthcare
MOH
$9.8B
| $31.1M | 4.34% | 97,893 -12,968 | -12% | -$4.12M |
|
|
12
UnitedHealth
UNH
$281B
| $30.1M | 4.2% | +60,000 | New | +$30.1M |
|
|
13
Surgery Partners
SGRY
$2.91B
| $29M | 4.05% | +543,696 | New | +$29M |
|
|
14
ICU Medical
ICUI
$3.15B
| $27.2M | 3.79% | +114,506 | New | +$27.2M |
|
15
Charles River Laboratories
CRL
$8.04B
| $26.4M | 3.68% | 70,000 +32,596 | +87% | +$12.3M |
|
16
Align Technology
ALGN
$10.3B
| $26.3M | 3.66% | 40,000 +5,000 | +14% | +$3.29M |
|
|
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $25.6M | 3.57% | 237,470 -336,997 | -59% | -$36.3M |
|
|
18
Hologic
HOLX
$14.9B
| $21.4M | 2.99% | 280,000 -320,000 | -53% | -$24.5M |
|
19
CONMED
CNMD
$1.68B
| $21.2M | 2.96% | 149,777 -40,223 | -21% | -$5.7M |
|
20
AdaptHealth
AHCO
$1.28B
| $17.1M | 2.39% | +700,000 | New | +$17.1M |
|
|
SLGC
21
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $16.7M | 2.33% | 1,437,246 +1,118,584 | +351% | +$13M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $16M | 2.23% | 24,000 -11,000 | -31% | -$7.34M |
|
23
Labcorp
LH
$23.1B
| $15.7M | 2.19% | +50,000 | New | +$15.7M |
|
24
Stereotaxis
STXS
$261M
| $11.3M | 1.58% | 1,826,728 -166,306 | -8% | -$1.03M |
|
|
OHPAU
25
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $9.91M | 1.38% | 1,006,229 | – | – |
|